# Safety, Tolerability, and Pharmacokinetic Study of CORT113176 in Healthy Participants

> **NCT04994743** · PHASE1 · COMPLETED · sponsor: **Corcept Therapeutics** · enrollment: 16 (actual)

## Conditions studied

- Healthy Adults

## Interventions

- **DRUG:** CORT113176
- **DRUG:** Placebo matching CORT113176

## Key facts

- **NCT ID:** NCT04994743
- **Lead sponsor:** Corcept Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-13
- **Primary completion:** 2021-09-30
- **Final completion:** 2021-09-30
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2021-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04994743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04994743, "Safety, Tolerability, and Pharmacokinetic Study of CORT113176 in Healthy Participants". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04994743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*